HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark A Gehrke Selected Research

EC0565

7/2015Antiinflammatory Activity of a Novel Folic Acid Targeted Conjugate of the mTOR Inhibitor Everolimus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark A Gehrke Research Topics

Disease

2Experimental Arthritis
07/2015 - 04/2011
2Inflammation (Inflammations)
07/2015 - 04/2011
2Rheumatoid Arthritis
07/2015 - 04/2011
1Arthritis (Polyarthritis)
04/2011

Drug/Important Bio-Agent (IBA)

2Folic Acid (Vitamin M)FDA LinkGeneric
07/2015 - 04/2011
1EC0565IBA
07/2015
1AminopterinIBA
04/2011
1Etanercept (Enbrel)FDA Link
04/2011
1EC 0746IBA
04/2011
1Methotrexate (Mexate)FDA LinkGeneric
04/2011